Evidence map›Paper›PMID 41186948›Full record

ArticleJAMA network open2025

Strategies to Reduce Advanced Imaging in Antenatal Pulmonary Embolism Diagnostics.

David R Vinson, Madeline J Somers, Lara Zekar, Edward Qiao, Cydney E Middleton, Sara T Woldemariam, Nachiketa Gupta, Luke S Poth, Mary E Reed, Jeffrey D Sperling and 1 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David R VinsonThe Permanente Medical Group, Pleasanton, California.
Madeline J SomersKaiser Permanente Division of Research, Pleasanton, California.
Lara ZekarUC Davis Health, University of California, Davis, Sacramento.
Edward QiaoCalifornia Northstate University School of Medicine, Elk Grove.
Cydney E MiddletonUC Davis Health, University of California, Davis, Sacramento.
Sara T WoldemariamThe Permanente Medical Group, Pleasanton, California.
Nachiketa GuptaThe Permanente Medical Group, Pleasanton, California.
Luke S PothThe Permanente Medical Group, Pleasanton, California.
Mary E ReedKaiser Permanente Division of Research, Pleasanton, California.
Jeffrey D SperlingThe Permanente Medical Group, Pleasanton, California.
Nareg H RoubinianThe Permanente Medical Group, Pleasanton, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Advanced imaging to diagnose pulmonary embolism (PE) during pregnancy increases costs, ionizing radiation exposure, and the risk of overdiagnosis. D-dimer testing can exclude PE and compression ultrasonography can diagnose deep vein thrombosis (DVT), both reducing advanced imaging needs. How these 2 strategies are used in community PE diagnostics is unknown. Objective: To analyze the use and efficiencies of D-dimer and ultrasonography for the diagnosis of antenatal PE. Design, Setting, and Participants: This retrospective cohort study was performed in 21 US community hospitals from October 1, 2021, to March 31, 2023. Participants included pregnant patients who underwent D-dimer testing, compression ultrasonography, or advanced imaging for suspected PE. Exposures: D-dimer testing or ultrasonography. Main Outcomes and Measures: The main outcome was avoidance of advanced imaging, measured by the number needed to test (NNT) to avoid 1 advanced imaging study using low to intermediate D-dimer values or a positive ultrasonography finding. Variables associated with D-dimer and ultrasonography were evaluated using quasi-Poisson regression reported as adjusted relative risks (ARRs). Results: A total of 720 outpatient encounters in 699 patients were included in the analysis (median age, 30.2 [IQR, 24.3-36.1] years). D-dimer testing was obtained in 524 patients (72.8%). Advanced imaging was not pursued in 149 of 155 patients (96.1%) with low (<0.5 mg/L) and 82 of 179 (45.8%) with intermediate (0.5 to <1.0 mg/L) D-dimer values, yielding an NNT to avoid 1 advanced imaging study of 2.3 (95% CI, 2.0-2.6). No 90-day venous thromboembolism or death occurred following rule-outs. D-dimer testing was less commonly used in third (vs first) trimester (ARR, 0.85; 95% CI, 0.75-0.97); with unilateral signs or symptoms of DVT (vs none) (ARR, 0.67; 95% CI, 0.54-0.82), and during labor and delivery unit (vs emergency department) evaluation (ARR, 0.27; 95% CI, 0.20-0.35). Compression ultrasonography was performed in 229 patients (31.8%), with DVT diagnosed in 3 (1.3%). Advanced imaging was not pursued in 2 of these patients, yielding an NNT to avoid 1 advanced imaging study of 115 (95% CI, 32-417). Ultrasonography use and results varied by DVT symptoms. Among 55 patients with DVT symptoms, 46 (83.6%) underwent ultrasonography, with positive findings in 3 (yield of 6.5%). Among 665 patients without symptoms, 183 (27.5%) underwent ultrasonography, with negative findings in all (yield of 0). Conclusions and Relevance: In this cohort study, use of D-dimer testing was efficient and safe with opportunities for expansion across settings and patients. These findings suggest that ultrasonography efficiency was low but could be improved with symptom-driven use in antenatal PE diagnostics.

Indexed as

Prenatal DiagnosisPulmonary EmbolismUltrasonography, PrenatalAdultFemaleFibrin Fibrinogen Degradation ProductsHumansPregnancyRetrospective StudiesUltrasonographyVenous ThrombosisYoung AdultFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID41186948
PMCPMC12587194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.